Image 1
Lansoprazole Capsule, Delayed Release
Product Images NDC 0093-7350
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 0093-7350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
This is a chart or table that shows the mean severity of night heartburn for evaluable patients. The severity is measured from 0 to 3, where 0 means none, 1 is mild, 2 is moderate, and 3 is severe. The chart compares the severity of night heartburn for patients taking a placebo, patients taking 15 mg QD of Lansoprazole, and patients taking 30 mg QD of Lansoprazole at different times from the start of treatment, from 5 to 56 days.*
Image 4
This is a code for a package of Lansoprazole delayed-release capsules with a total of 30 capsules. The code is © 95-0552-5600 and the product information cannot be deemed available from the provided text.*
Image 5
This appears to be a label of a medication called "Lansoprazole Delayed-Release Capsules, USP". It comes in a bottle containing 30 capsules. The phone number "95-1551-5600" and reference number "NoC0053 735155" are also included.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
